First author:

Lin LY*, Chun Chang S, O'Hearn J, Hui ST, Seldin M, Gupta P, Bondar G, Deng M, Jauhiainen R, Kuusisto J, Laakso M, Sinsheimer JS, Deb A, Rau C, Ren S, Wang Y, Lusis AJ, Wang JJ, Huertas-Vazquez A. Systems Genetics Approach to Biomarker Discovery: GPNMB and Heart Failure in Mice and Humans. G3 (Bethesda). 2018 6;8:3499-3506. [IF: 3.542]

通訊作者:

Chang LH, Chu CH, Huang CC, Lin LY*. Fibroblast Growth Factor 21 Levels Exhibit the Association With Renal Outcomes in Subjects With Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne). 2022 21;13:846018. [IF:6.055]

Wu TH, Chang LH, Chu CH, Hwu CM, Chen HS, Lin LY*. Soluble tumor necrosis factor receptor 2 is associated with progressive diabetic kidney disease in patients with type 2 diabetes mellitus. PLoS One. 2022 12;17:e0266854. [IF: 3.752]

Chang LH, Hwu CM, Chu CH, Lin YC, Huang CC, You JY, Chen HS, Lin LY*. The combination of soluble tumor necrosis factor receptor type 1 and fibroblast growth factor 21 exhibits better prediction of renal outcomes in patients with type 2 diabetes mellitus. J Endocrinol Invest. 2021;44:2609-2619. [IF: 5.467]

Chang LH, Hwu CM, Lin YC, Huang CC, Won JGS, Chen HS, Lin LY*. SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TYPE 1 LEVELS EXHIBIT THE BETTER ASSOCIATION WITH RENAL OUTCOMES THAN TRADITIONAL RISK FACTORS IN CHINESE SUBJECTS WITH TYPE 2 DIABETES MELLITUS. Endocr Pract. 2020 23. [IF: 3.701]